Exelixis Inc (EXEL)
23.70
+0.16
(+0.70%)
USD |
NASDAQ |
Apr 26, 16:00
23.70
0.00 (0.00%)
After-Hours: 19:03
Exelixis Total Liabilities (Quarterly): 678.44M for Dec. 31, 2023
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 678.44M |
September 30, 2023 | 629.29M |
June 30, 2023 | 614.53M |
March 31, 2023 | 588.22M |
December 31, 2022 | 583.06M |
September 30, 2022 | 469.97M |
June 30, 2022 | 490.14M |
March 31, 2022 | 360.27M |
December 31, 2021 | 405.62M |
September 30, 2021 | 335.29M |
June 30, 2021 | 324.19M |
March 31, 2021 | 279.36M |
December 31, 2020 | 258.22M |
September 30, 2020 | 259.01M |
June 30, 2020 | 213.22M |
March 31, 2020 | 207.95M |
December 31, 2019 | 199.70M |
September 30, 2019 | 181.15M |
June 30, 2019 | 154.47M |
March 31, 2019 | 156.77M |
December 31, 2018 | 134.83M |
September 30, 2018 | 108.40M |
June 30, 2018 | 136.19M |
March 31, 2018 | 105.15M |
December 31, 2017 | 370.33M |
Date | Value |
---|---|
September 30, 2017 | 371.06M |
June 30, 2017 | 368.02M |
March 31, 2017 | 467.23M |
December 31, 2016 | 506.42M |
September 30, 2016 | 516.47M |
June 30, 2016 | 663.27M |
March 31, 2016 | 648.49M |
December 31, 2015 | 473.15M |
September 30, 2015 | 437.47M |
June 30, 2015 | 436.97M |
March 31, 2015 | 429.69M |
December 31, 2014 | 438.10M |
September 30, 2014 | 442.17M |
June 30, 2014 | 437.39M |
March 31, 2014 | 426.08M |
December 31, 2013 | 437.05M |
September 30, 2013 | 423.20M |
June 30, 2013 | 415.75M |
March 31, 2013 | 404.68M |
December 31, 2012 | 424.66M |
September 30, 2012 | 421.77M |
June 30, 2012 | 275.44M |
March 31, 2012 | 280.25M |
December 31, 2011 | 302.63M |
September 30, 2011 | 408.58M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
154.47M
Minimum
Jun 2019
678.44M
Maximum
Dec 2023
380.64M
Average
335.29M
Median
Sep 2021
Total Liabilities (Quarterly) Benchmarks
Regeneron Pharmaceuticals Inc | 7.107B |
Bristol-Myers Squibb Co | 65.67B |
Johnson & Johnson | 98.78B |
Bio-Techne Corp | 767.19M |
Legend Biotech Corp | 597.24M |
Total Liabilities (Quarterly) Related Metrics
Total Assets (Quarterly) | 2.942B |
Shareholders Equity (Quarterly) | 2.264B |
Current Ratio | 3.343 |